Chinese Cardiologists' Knowledge/Practices on Flu Vaccine for Chronic Coronary Syndrome
Launched by THE AFFILIATED HOSPITAL OF HANGZHOU NORMAL UNIVERSITY · May 19, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well cardiologists in China understand the importance of flu vaccinations for patients with chronic coronary syndrome (CCS), which is a condition that affects heart health. The goal is to find out what doctors know about flu shots, where there might be misunderstandings, and what factors influence their recommendations to patients. By gathering this information, the study aims to improve education for doctors and help them better manage CCS patients, ultimately reducing the risk of serious complications from the flu.
To participate in this study, doctors need to be licensed cardiologists who have a good understanding of how flu vaccinations relate to heart diseases. Unfortunately, doctors from other specialties, like surgery or emergency medicine, will not be included. The study will involve filling out a questionnaire, and while it is not yet recruiting participants, it is an important step toward ensuring that heart patients receive the best possible care during flu season.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cardiologists (licensed practitioners) with specialized knowledge of the association between influenza vaccination and cardiovascular diseases.
- Exclusion Criteria:
- • Physicians from non-cardiology specialties (e.g., surgery, general internal medicine \[including respiratory and gastroenterology departments\], emergency medicine).
- • Physicians unable to complete the questionnaire survey.
About The Affiliated Hospital Of Hangzhou Normal University
The Affiliated Hospital of Hangzhou Normal University is a prestigious medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital leverages its robust academic resources and experienced faculty to facilitate cutting-edge studies that aim to improve patient outcomes and contribute to the medical community's understanding of various health conditions. Committed to ethical standards and regulatory compliance, the hospital fosters collaboration among multidisciplinary teams, ensuring the highest quality of care and scientific rigor in all its clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hanzhou, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported